E D Geijsen
Overview
Explore the profile of E D Geijsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Doesburg J, Luttikhold J, Lindblad M, van Berge Henegouwen M, Eshuis W, Derks S, et al.
Eur J Surg Oncol
. 2023 Dec;
50(2):107318.
PMID: 38145609
Background: Rapid and complete workup of newly diagnosed esophageal cancer is vital for a timely, individual and high-quality treatment strategy. The aim of this study was to uncover potential delay,...
2.
van de Water L, Kuijper S, Henselmans I, van Alphen E, Kooij E, Calff M, et al.
EClinicalMedicine
. 2023 Oct;
64:102244.
PMID: 37781156
Background: For cancer patients to effectively engage in decision making, they require comprehensive and understandable information regarding treatment options and their associated outcomes. We developed an online prediction tool and...
3.
Ende T, de Clercq N, van Berge Henegouwen M, Gisbertz S, Geijsen E, Verhoeven R, et al.
Clin Cancer Res
. 2021 Jan;
27(12):3351-3359.
PMID: 33504550
Purpose: The CROSS trial established neoadjuvant chemoradiotherapy (nCRT) for patients with resectable esophageal adenocarcinoma (rEAC). In the PERFECT trial, we investigated the feasibility and efficacy of nCRT combined with programmed-death...
4.
Middelburg J, Middelburg R, van Zwienen M, Mast M, Bhawanie A, Jobsen J, et al.
Clin Oncol (R Coll Radiol)
. 2020 Sep;
33(4):e203-e210.
PMID: 32972801
Aims: To investigate whether the Geriatric 8 (G8) score and the Timed Get Up and Go Test (TGUGT), together with clinical and demographic patient characteristics, are associated with survival and...
5.
de Jong R, Crama K, Visser J, van Wieringen N, Wiersma J, Geijsen E, et al.
Radiat Oncol
. 2020 Jul;
15(1):162.
PMID: 32641080
Background: To compare online adaptive radiation therapy (ART) to a clinically implemented plan selection strategy (PS) with respect to dose to the organs at risk (OAR) for rectal cancer. Methods:...
6.
de Jong R, Visser J, Crama K, van Wieringen N, Wiersma J, Geijsen E, et al.
Radiat Oncol
. 2020 Jan;
15(1):13.
PMID: 31931829
Background: To compare target coverage and dose to the organs at risk in two approaches to rectal cancer: a clinically implemented adaptive radiotherapy (ART) strategy using plan selection, and a...
7.
Schooneveldt G, Kok H, Bakker A, Geijsen E, Hulshof M, de Reijke T, et al.
Int J Hyperthermia
. 2018 Oct;
35(1):441-449.
PMID: 30303415
Purpose: Loco-regional hyperthermia combined with mitomycin C is used for treatment of nonmuscle invasive bladder cancer (NMIBC). Air pockets may be present in the bladder during treatment. The aim of...
8.
Kok H, Schooneveldt G, Bakker A, de Kroon-Oldenhof R, Korshuize-van Straten L, de Jong C, et al.
Int J Hyperthermia
. 2018 Oct;
35(1):330-339.
PMID: 30300028
Introduction: On-line adaptive hyperthermia treatment planning can be useful to suppress treatment limiting hot spots and improve tumor temperatures during locoregional hyperthermia. This requires adequate prediction of changes in heating...
9.
Schooneveldt G, Kok H, Balidemaj E, Geijsen E, van Ommen F, Sijbrands J, et al.
Med Phys
. 2016 Oct;
43(10):5442.
PMID: 27782702
Purpose: Hyperthermia is an established (neo)adjuvant treatment modality for a number of pelvic malignancies. Optimal treatment of these tumors requires robust treatment planning, but up until now, the urinary bladder...
10.
Jeene P, Versteijne E, van Berge Henegouwen M, Bergmann J, Geijsen E, Muller K, et al.
Dis Esophagus
. 2016 Oct;
30(2):1-5.
PMID: 27766725
The aim of this study was to determine the outcome of salvage definitive chemoradiation (dCRT) for a locoregional recurrence after any prior curative treatment outside previously irradiated areas. Thirty-nine patients...